Incidence and feasibility of coronary access after transcatheter aortic valve replacement

Luca Nai Fovino1, Andrea Scotti1, Mauro Massussi1

  • 1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.

Insights

Coronary access after transcatheter aortic valve replacement (TAVR) is uncommon long-term. Coronary access and intervention (PCI) are generally safe and successful post-TAVR, though supra-annular devices may pose challenges.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Long-term incidence of coronary access (CA) following transcatheter aortic valve replacement (TAVR) is not well-established.
  • Coronary interventions post-TAVR may encounter technical difficulties, especially with supra-annular valve deployment.

Purpose of the Study:

  • To determine the incidence, feasibility, and outcomes of coronary access after TAVR.
  • To identify predictors of coronary access post-TAVR.
  • To assess the safety and success rates of percutaneous coronary intervention (PCI) after TAVR.

Main Methods:

  • Retrospective analysis of 912 patients who underwent TAVR between 2007 and 2018.
  • Inclusion criteria: patients undergoing CA post-TAVR (excluding in-TAVR coronary obstruction).
  • Data collected: incidence, procedural success, outcomes, and predictors of CA.

Main Results:

  • The incidence of CA post-TAVR was 5.3% (48/912 patients) at a median follow-up of 769 days.
  • PCI was indicated in 54% of cases, with 35% for acute coronary syndromes (ACS).
  • Coronary access was feasible in all intra-annular device cases, but not in two supra-annular valve cases; PCI success rate was 98%.
  • Younger age, prior PCI, and prior CABG were predictors of CA post-TAVR.

Conclusions:

  • Coronary access post-TAVR in high-risk aortic stenosis patients is infrequent.
  • Coronary access and PCI are safe and effective procedures after TAVR.
  • Supra-annular valve placement may be associated with a reduced rate of selective coronary access.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
500
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
327
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
321